Paper Report for: Sekuri_2006_Anadolu.Kardiyol.Derg_6_132
Reference
Title: Association of platelet-activating factor acetylhydrolase gene polymorphism with premature coronary artery disease in Turkish patients Sekuri C, Cam FS, Tengiz I, Ercan E, Bayturan O, Berdeli A Ref: Anadolu Kardiyol Derg, 6:132, 2006 : PubMed
OBJECTIVE: Platelet-activating factor (PAF) is a phospholipid with multiple actions that is involved in inflammatory diseases as well as in atherogenesis. It is inactivated by a plasma enzyme, PAF-acetylhydrolase (PAF-AH). Deficiency of this enzyme in plasma is caused by a missense mutation in the gene (G994T). The aim of this study was to investigate association of this mutation with premature coronary artery disease (CAD). METHODS: One hundred and fifteen unrelated Turkish patients with a diagnosis of premature CAD and 128 unrelated healthy subjects were enrolled in this study. Genotyping was performed by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP). RESULTS: The prevalence of the G994T mutation in the patients was 2.60 % (heterozygote), and 0 % in the controls. There was no significant difference in allele frequency and genotype distribution among the study groups. CONCLUSION: The G9943T mutation in the plasma PAF acetylhydrolase gene is not associated with premature CAD in Turkish subjects.
Sekuri C, Cam FS, Tengiz I, Ercan E, Bayturan O, Berdeli A (2006) Association of platelet-activating factor acetylhydrolase gene polymorphism with premature coronary artery disease in Turkish patients Anadolu Kardiyol Derg6: 132-4
Sekuri C, Cam FS, Tengiz I, Ercan E, Bayturan O, Berdeli A (2006) Anadolu Kardiyol Derg6: 132-4
